Drug General Information |
Drug ID |
D00FHR
|
Former ID |
DCL001114
|
Drug Name |
MGCD-0103
|
Synonyms |
Mocetinostat; MG 0103; MG 4230; MG 4915; MG 5026; MG0103; MG4230; MG4915; MG5206; MGCD 0103; MGCD0103; MG-0103; MG-4230; MG-4915; MG-5026; Mocetinostat, MGCD0103; N-(2-aminophenyl)-4-[[(4-pyridin-3-ylpyrimidin-2-yl)amino]methyl]benzamide; N-(2-Aminophenyl)-4-((4-pyridin-3-ylpyrimidin-2-ylamino)methyl)benzamide
|
Drug Type |
Small molecular drug
|
Therapeutic Class |
Anticancer Agents
|
Company |
MethylGene Inc
|
Structure |
|
Download
2D MOL
3D MOL
|
Formula |
C23H20N6O
|
InChI |
InChI=1S/C23H20N6O/c24-19-5-1-2-6-21(19)28-22(30)17-9-7-16(8-10-17)14-27-23-26-13-11-20(29-23)18-4-3-12-25-15-18/h1-13,15H,14,24H2,(H,28,30)(H,26,27,29)
|
InChIKey |
HRNLUBSXIHFDHP-UHFFFAOYSA-N
|
PubChem Compound ID |
|
PubChem Substance ID |
14830272, 24157526, 45287781, 56269575, 57373597, 75001461, 87226489, 87350368, 99436992, 103571737, 124490381, 124757017, 125163821, 125570876, 126671642, 131480763, 134964362, 135200342, 135723831, 136340181, 136367318, 136367876, 136920348, 137061752, 137276026, 142701494, 144116214, 152254622, 152258401, 152344187, 160647238, 162011468, 162037450, 162202711, 164042034, 164193968, 171578666, 172914178, 174007066, 174530499, 175608166, 177748388, 178103587, 186007035, 187071895, 188899510, 198936135, 218902997, 223387412, 223679945
|
Target and Pathway |
References |